Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW)

CUSIP: 68236X118

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / *W EXP 99/99/999
Total 13F shares
3,520,379
Share change
-63,974
Total reported value
$94,854
Price per share
$0.03
Number of holders
11
Value change
-$299
Number of buys
1
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 68236X118?
CUSIP 68236X118 identifies TOIIW - Oncology Institute, Inc. - *W EXP 99/99/999 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) as of Q1 2025

As of 31 Mar 2025, Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,520,379 shares. The largest 10 holders included LMR Partners LLP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Davidson Kempner Capital Management LP, Man Group plc, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, WOLVERINE ASSET MANAGEMENT LLC, Alpine Global Management, LLC, TENOR CAPITAL MANAGEMENT Co., L.P., FreeGulliver LLC, and CLEAR STREET LLC. This page lists 11 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.